$3.62 (-3.47%)

Volume: 150.592k

Closed: Dec 02, 2022

Hollow Logo Score: 1.672

ESSA Pharma Inc. Stock Forecast

$3.62 (-3.47%)

Volume: 150.592k

Closed: Dec 02, 2022

Score Hollow Logo 1.672

ESSA Pharma Inc. Stock Statistics NASDAQ:EPIX

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior. Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average. Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Dates Signal Change
2022-10-28 - 2022-12-02 BUY -17.91
2022-10-26 - 2022-10-28 HOLD -8.51
2022-10-19 - 2022-10-26 SELL 141.00
2022-10-18 - 2022-10-19 BUY -4.76
2022-10-14 - 2022-10-18 SELL 7.14

Stock Score Effectiveness

Bollinger Stock Signal Effectiveness

Macd Signal Effectiveness

Mv7 Signal Effectiveness

Score signal

Bollinger Signal Statistics

MV signal statistics

MACD Signal Statistics

Hot Stocks To Watch:

About ESSA Pharma Inc.

ESSA Pharma ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreements with Caris Life Sciences, Inc.; Bayer Consumer Care AG; Janssen Research & Development, LLC; and A... EPIX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT